Omada Health (OMDA) Cash from Financing Activities (2024 - 2026)

Omada Health has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $7.6 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 95.31% year-over-year to $7.6 million; the TTM figure through Jun 2026 stood at -$18.6 million (down 111.45% YoY), while the FY2025 annual figure was $133.2 million, up 11119.35% from the prior year.
• Cash from Financing Activities came in at $7.6 million for Q2 2026 at Omada Health, up from $3.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $162.1 million in Q2 2025 to a low of -$32.7 million in Q3 2025.
• Average Cash from Financing Activities over 3 years is $18.0 million, with a median of $1.7 million recorded in 2025.
• The largest YoY upside for Cash from Financing Activities was 2887.61% in 2025 against a maximum downside of 7604.01% in 2025.
• Over 3 years, Cash from Financing Activities stood at $113000.0 in 2024, then soared by 2887.61% to $3.4 million in 2025, then surged by 125.24% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $7.6 million in Q2 2026, $3.1 million in Q1 2026, and $3.4 million in Q4 2025.